Abstract
A growing body of epidemiologic and clinical evidence points to a significant role of biobehavioral and associated neuroendocrine factors on cancer growth and progression. This review provides an overview of the emerging relationships between neuroendocrine pathways and ovarian cancer progression. The primary focus of this review is on the contributions of neuroendocrine influences on cancer cell biology and tumor microenvironment in ovarian cancer. This mechanistic understanding will inform new opportunities for pharmacological and behavioral interventions for improving the outcome of ovarian cancer patients.
Keywords: Neuroendocrine, Ovarian cancer, Stress, Angiogenesis, Anoikis
Current Cancer Therapy Reviews
Title:Stress Related Neuroendocrine Influences in Ovarian Cancer
Volume: 8 Issue: 2
Author(s): Yu Kang, Susan K. Lutgendorf, Wei Hu, Steven W. Cole and Anil K. Sood
Affiliation:
Keywords: Neuroendocrine, Ovarian cancer, Stress, Angiogenesis, Anoikis
Abstract: A growing body of epidemiologic and clinical evidence points to a significant role of biobehavioral and associated neuroendocrine factors on cancer growth and progression. This review provides an overview of the emerging relationships between neuroendocrine pathways and ovarian cancer progression. The primary focus of this review is on the contributions of neuroendocrine influences on cancer cell biology and tumor microenvironment in ovarian cancer. This mechanistic understanding will inform new opportunities for pharmacological and behavioral interventions for improving the outcome of ovarian cancer patients.
Export Options
About this article
Cite this article as:
Kang Yu, K. Lutgendorf Susan, Hu Wei, W. Cole Steven and K. Sood Anil, Stress Related Neuroendocrine Influences in Ovarian Cancer, Current Cancer Therapy Reviews 2012; 8 (2) . https://dx.doi.org/10.2174/157339412800675315
DOI https://dx.doi.org/10.2174/157339412800675315 |
Print ISSN 1573-3947 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6301 |
Call for Papers in Thematic Issues
Current progress in Protein Degradation and Cancer Therapy
argeted Protein Degradation is gaining momentum in cancer therapy, it facilitate targeting undruggable proteins, it overcome cancer resistance and avoid undesirable side effects. Thus small molecules degraders have emerged as novel therapeutic strategy. Targeted protein degradation (TPD), the process of eliminating a protein of interest hold a great promise for ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Chemoresistance in Ovarian Cancer: Prospects for New Drugs
Anti-Cancer Agents in Medicinal Chemistry Role of Cytokines in the Pathophysiology of Acute Graft-Versus-Host Disease (GVHD)– Are Serum/Plasma Cytokines Potential Biomarkers for Diagnosis of Acute GVHD Following Allogeneic Hematopoietic Cell Transplantation (Allo-HCT)?
Current Stem Cell Research & Therapy Opportunities and Challenges of Fluorescent Carbon Dots in Translational Optical Imaging
Current Pharmaceutical Design Editorial [Hot Topic: Evolving Drug Targets in DNA Base Excision Repair for Cancer Therapy (Guest Editor: Srinivasan Madhusudan)]
Current Molecular Pharmacology Molecular Targeting of Cell Death Signal Transduction Pathways in Cancer
Current Signal Transduction Therapy ABC Transporters in the Development of Multidrug Resistance in Cancer Therapy
Current Pharmaceutical Design The Renin-angiotensin System as a Target of Novel Anticancer Therapy
Current Pharmaceutical Design TRAIL as Biomarker and Potential Therapeutic Tool for Cardiovascular Diseases
Current Drug Targets Ruthenium Antimetastatic Agents
Current Topics in Medicinal Chemistry From Natural Products to Designer Drugs: Development and Molecular Mechanisms Action of Novel Anti-Microtubule Breast Cancer Therapeutics
Current Topics in Medicinal Chemistry Metabolomics Analysis for Biomarker Discovery: Advances and Challenges
Current Medicinal Chemistry FOXP2 Promotes Tumor Proliferation and Metastasis by Targeting GRP78 in Triple-negative Breast Cancer
Current Cancer Drug Targets The Use of Nimesulide and Its Analogues in Cancer Chemoprevention
Anti-Cancer Agents in Medicinal Chemistry Drug Targeting Systems for Cancer Therapy: Nanotechnological Approach
Mini-Reviews in Medicinal Chemistry Fc-fusion Proteins in Therapy: An Updated View
Current Medicinal Chemistry Two Panels of Steroid Receptor Luciferase Reporter Cell Lines for Compound Profiling
Combinatorial Chemistry & High Throughput Screening Patent Selections
Recent Patents on Anti-Cancer Drug Discovery Peptides to Target Tumor Vasculature and Lymphatics for Improved Anti-Angiogenesis Therapy
Current Cancer Drug Targets Wnt Signaling and Potential Applications in Bone Diseases
Current Drug Targets Clinical Advances in Hypomethylating Agents Targeting Epigenetic Pathways
Current Cancer Drug Targets